| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-06 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.17 | 6e-06 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.14 | 7e-06 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-06 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-06 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-06 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |